Skye Bioscience Inc (SKYE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 10-2012 | 12-2011 | 12-2006 | 12-2005 | |
| Sales | 16 | 16 | 0 | 0 |
| Cost of Goods | 5 | 5 | N/A | N/A |
| Gross Profit | 11 | 11 | N/A | N/A |
| Operating Expenses | 12 | 12 | 0 | 0 |
| Operating Income | 4 | 4 | N/A | N/A |
| Other Income | 1 | 1 | 0 | 0 |
| Pre-tax Income | 5 | 5 | 0 | 0 |
| Net Income Continuous | 5 | 5 | N/A | N/A |
| Net Income | $5 | $5 | $N/A | $N/A |
| EPS Basic Continuous Ops | 0.54 | N/A | N/A | N/A |
| EPS Diluted Continuous Ops | 0.54 | N/A | N/A | N/A |
| EBITDA(a) | $4 | $4 | $N/A | $N/A |